Cite
Findings from Regeneron Pharmaceuticals Inc. in Lipoproteins Reported [Low prevalence of testing for apolipoprotein B and lipoprotein (a) in the real world]
MLA
“Findings from Regeneron Pharmaceuticals Inc. in Lipoproteins Reported [Low Prevalence of Testing for Apolipoprotein B and Lipoprotein (a) in the Real World].” Obesity, Fitness & Wellness Week, Oct. 2024, p. 2001. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.811278045&authtype=sso&custid=ns315887.
APA
Findings from Regeneron Pharmaceuticals Inc. in Lipoproteins Reported [Low prevalence of testing for apolipoprotein B and lipoprotein (a) in the real world]. (2024, October 12). Obesity, Fitness & Wellness Week, 2001.
Chicago
Obesity, Fitness & Wellness Week. 2024. “Findings from Regeneron Pharmaceuticals Inc. in Lipoproteins Reported [Low Prevalence of Testing for Apolipoprotein B and Lipoprotein (a) in the Real World],” October 12. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.811278045&authtype=sso&custid=ns315887.